Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.
about
Statins and its hepatic effects: Newer data, implications, and changing recommendationsEffect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.Childhood cardiovascular risk factors, a predictor of late adolescent overweight.Hypothyroidism and Lipid Levels in a Community Based Study (TTS).Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice.Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial
P2860
Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@ast
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@en
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@nl
type
label
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@ast
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@en
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@nl
prefLabel
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@ast
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@en
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@nl
P2860
P921
P356
P1476
Statin therapy and hepatotoxic ...... in in hyperlipidemic patients.
@en
P2093
Mohammadreza Naghipour
Saeed Kalantari
P2860
P356
10.4103/2277-9175.139133
P577
2014-08-19T00:00:00Z